Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Delight of Perusing: Book Proposals for Each Class - 2The most effective method to Plan an Incineration Administration: A Bit by bit Guide.
- 3Couch Styles of 2024: What's Moving
- 4FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
- 5Black Friday streaming deals 2025: Grab the Disney+ Hulu bundle for only $5 and save over 60%
- My daughter is in the #1 movie in the country. She still has to finish her math homework.
- Scientists captured female sperm whales on video working together during a birth to protect the calf
- 2024 Watch Gathering: The Best Watches of the Year
- Far-right German youth group delegates seek deportations, remigration
- Daily Briefing: A bad flu season gets worse
- 7 Powerful Techniques to Boost Efficiency with Your Cell Phone: A Far reaching Guide
- This Week In Space podcast: Episode 188 — A New NASA Leader Rises?
- The most effective method to Augment Benefits in Gold Speculation: Systems and Tips
- With more Moon missions on the horizon, avoiding crowding and collisions will be a growing challenge
